On March 1st, 2021, iTakeControl joined Red Nucleus and expands its platform and offerings globally.
iTakeControl enables new patient-centric R&D approaches in genomic research, gene therapy, rare and personalized medicine with our services, technology, and operational expertise.
Prospective Clinical Trials
Real World Evidence
Strategy and Governance
Why iTakeControl?
We have a fully integrated and comprehensive platform that enables you to quickly customize a mobile health solution for Real World Disease Management, Clinical Trial Management and R&D Management.
Strategic
Supplement your team with strategic insight and innovative program management in a collaborative approach with your internal clinical and compliance teams for program value and research gaps.
Agile
Don’t just “build a survey” or build a “form.” Design the right mobile experience for unique disease or condition progression.
Experienced
Extend your team with experienced biotech industry team members with digital strategy, GxP clinical process, and UX/UI experts.
“It’s a rapidly changing environment. We launched iTakeControl to enable biopharma to navigate these changes and feel confident in launching new digital research and training programs. We’re here because we want to see new data, faster research, and high quality training in the hands of patients and industry professionals alike.”
Dalia El-Sherif, Co-founder & Board Member
